ADVR More DD:
compiled by Counsellor at the RagingBull ADVR Board:
IDSA 2000 September 7-10 New Orleans
home page
idsociety.org
September 7 - 10, 2000
9/8/00 12:00 PM
Product R, a Peptide Regulator of Human Papilloma Virus-18 E7 in HeLa Cells
9/8/00 12:00 PM
Inhibition of Adenovirus E1A Expression in HeLa Cells by Product R, a New Anti-Viral
Reagent
9/8/00
12:00 - 2:00 pm
Poster Discussion Rounds
This new session highlights selected poster abstracts detailing new scientific and
clinical findings in the following categories.
There are no additional fees to attend these sessions; however, preregistration is
required as attendance is limited to 15 participants per group.
Antifungal Agents and Fungal Infections
Group Leader: John Bennett, MD, NIH, Bethesda, MD
Bacterial Infections
Group Leader: John G. Bartlett, MD, Johns Hopkins Univ. Sch. of Med., Baltimore, MD
HIV Infection and AIDS
Group Leader: William G. Powderly, MD, Washington Univ., St. Louis, MO
Viral Infections (other than HIV)
Group Leader: Richard J. Whitely, MD, Univ. of Alabama at Birmingham, Birmingham,
Alabama
ADVR Due Diligence
Company web site
adviral.com
Current interview with Dr. Hirschman
ceocast.com
from 7/6/2000 – register for free
International AIDS conference in South Africa
aids2000.com
News releases
"A Big Home For Big Dreams" July 17, 2000 Advanced Viral Research Corp. cover story in The Journal News Business Section
nyjournalnews.com
Advanced Viral Research Corp. Triples Size of Research and Development Facilities
biz.yahoo.com
PR on CEO’s interview
biz.yahoo.com
Advanced Viral Research Corp. Cites Influence of 'Product R' On Opportunistic Infections
biz.yahoo.com
Advanced Viral Research Corp. to Present At 38th Annual Meeting of the Infectious Diseases Society of America
biz.yahoo.com
Corporate Profile
biz.yahoo.com
Antiviral From Advanced Viral Research Corp. Inhibits Production of a Key Cervical
Cancer-Causing Protein of the Human Papilloma Virus
biz.yahoo.com
Antiviral from Advanced Viral Research Corp. Inhibits CCR5 Cell Receptor for HIV
nolanmadson.com
Title: ASM MEETING: Reticulose Stimulates Immune System Without Increasing HIV Viral Load
docguide.com
( BW)(NY-ADVANCED-VIRAL)(ADVR) Advanced Viral Research Corp. Receives Approval in Argentina for Human Clinical Studies With "Substance R"
fitness.guidesmart.com
Controlled Trial of a New Non-Toxic Drug, Reticulose, in the Treatment of Patients with HIV/AIDS
dev.asmusa.org
Patient Awareness of Treatment Options Fuels Growth of HIV/AIDS Therapeutic Markets
frost.com
Conference
healthtech.com
The largest HIV/AIDS website in the world
aegis.com
Profile
marketguide.com
Chart
stockmaster.com
Peptide nucleic acid Jump station
horizonpress.com
Combination Therapies for HCV
home.texoma.com
AIDS treatment news archive
immunet.org
Positive health news (1995) – scroll down a bit
execpc.com
Expanded Access Programs
critpath.org
Testimonial letter to Mr. Bregman at ADVR from 1992
hsph.harvard.edu
Here is a REALLY old one…but interesting
The following information is the Cover Story from PENNY STOCK MAGAZINE
Volume 2, Number 4, dated April 1987
shoppingonthenet.com
very LONG article (178 pages) on Hepatitis C– go to section IV.0.6 RETICULOSE
members.bellatlantic.net
From the Infectious Disease News – 1996
slackinc.com
November 1999 Cambridge Healthtech Institute Chemokines Conference
healthtech.com
next conference - November 2000 in MacLean Va.
American Society for Microbiology 21-May-98
New Non-Toxic Drug for AIDS
newswise.com
Product R – but it costs 2 bucks
bioscorpio.com R
NATUROPATHIC HERPES "CURE" FACTSHEET vers. 0.15 Apr. 20, 1999
Scroll waaaaaay down
eff.org
From Dr. Hirschman in 1996 and one from Friedland
ncbi.nlm.nih.gov:80/entrez/query.fcgi?CMD=Display&DB=PubMed
Centerwatch Clinical Trials Listing Service
centerwatch.com
Canine distemper virus patent - 5,807,840
bioinfo.com
Patent 5,849,196
164.195.100.11
Patent 5,807,839
164.195.100.11
Reticulose mentioned in this article
abcnews.go.com
tess.uspto.gov
Word Mark
RETICULOSE
Goods and Services
IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical peptide-nucleic acid solution for the treatment of viral diseases in humans, namely, influenza, viral hepatitis, mumps orchitis, viral
pneumonia, mononucleosis, herpes, and human immunodeficiency virus. FIRST USE:
19921223. FIRST USE IN COMMERCE: 19921223
trademarks.uspto.gov
trademark info
newsday article
newsday.com
news article in The Journal News
nyjournalnews.com
AIDS Activists call for Fast Track
prnewswire.com
newsalert.com
SECinfo.com - register for FREE and then search for Advanced Viral Research.
All the SEC doecuments are there in a "clickable" format - very easy to read
secinfo.com
A reply to Aven1
webmd.lycos.com
Peptide nucleic acids stimulate gamma interferon and inhibit the replication of the human immunodeficiency virus.
infotrieve.com
The latest medical news and information for patients or friends/parents of patients diagnosed with AIDS/HIV.
pslgroup.com
Everything that's old is new again - 1996 article
slackinc.com
a little info on Advanced Viral Research
bioscorpio.com
RETICULOSE Significant CD4 Increases Documented
old article but it does list some Dr's who have used Reticulose in their practice
scroll waaaaay down
execpc.com
Registrant:
Advanced Viral Research (ADVIRAL-DOM)
1250 East Hallendale Beach Boulevard
Suite 501
Hallendale, FL 33009
US
Domain Name: adviral.com
Registrant:
Advanced Viral Research Corp (RETICULOSE-DOM)
PO Box 3947
Sarasota, FL 34230-3947
us
Domain Name: reticulose.com
Registrant:
Advanced Viral Research Corp. (ADVANCEDVIRAL-DOM)
PO Box 3947
Sarasota, FL 34230-3947
US
Domain Name: advancedviral.com
Registrant:
ADVANCED VIRAL RESEARCH (PEPTIGEN-DOM)
1250 Esat Hallendale Beach Blvd., Suite 5
HALLENDALE, FL 33009
US
Domain Name: peptigen.com
Registrant:
ADVANCED VIRAL RESEARCH (PEPTIGENBIOPHARM-DOM)
1250 Esat Hallendale Beach Blvd., Suite 5
HALLENDALE, FL 33009
US
Domain Name: peptigenbiopharm.com
Registrant:
INVERSIONES LATINAS (ADVANCEDVIRALRESEARCH-DOM)
709 WARBURTON AVE # 7C
YONKERS, NY 10701
US
Domain Name: advancedviralresearch.com |
